Form 8-K - Current report:
SEC Accession No. 0001453687-25-000104
Filing Date
2025-10-08
Accepted
2025-10-08 07:00:02
Documents
12
Period of Report
2025-10-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20251002.htm   iXBRL 8-K 32039
  Complete submission text file 0001453687-25-000104.txt   149449

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20251002.xsd EX-101.SCH 1862
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20251002_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20251002_pre.xml EX-101.PRE 12572
14 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20251002_htm.xml XML 2722
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 251381211
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)